Share：
Share this content in WeChat
X
[Chinese][PDF]89266
• Lectures •
MRI diagnosis of prostate cancer and the effect of MRI in the therapy selection of prostate cancer
CHEN Min  LI Chun-mei 

DOI:10.3969/j.issn.1674-8034.2011.03.013.


[Abstract] MR has been widely used in the diagnosis and evaluation of prostate cancer and plays an important part in the clinical diagnosis and treatment of prostate cancer. In order to improve the knowledge of MRI application in prostate cancer, this paper summarized the values of multiple MR techniques in the diagnosis of prostate cancer and made a brief introduction on the effect of MRI in the therapy selection of prostate cancer.
[Keywords] Prostate cancer；Magnetic resonance imaging；Diagnosis；Therapy

CHEN Min* Department of Radiology, Beijing Hospital, Beijing 100730, China

LI Chun-mei Department of Radiology, Beijing Hospital, Beijing 100730, China

*Correspondence to: Chen M, E-mail: chenmin62@yahoo.com

Conflicts of interest   None.

Received  2011-03-24
Accepted  2011-04-20
DOI: 10.3969/j.issn.1674-8034.2011.03.013
DOI:10.3969/j.issn.1674-8034.2011.03.013.

[1]
Jemal A, Siegel R, Ward E, et al. Cancer statistics. CA Cancer J Clin, 2007, 57(1):43-66.
[2]
Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics. CA Cancer J Clin, 2002, 55(2):74-108.
[3]
王建业，陈鑫，刘明，等. MRI在前列腺癌诊断和治疗中的应用．磁共振成像, 2010, 1(4): 253-256.
[4]
李春媚，陈敏，李飒英，等．前列腺癌的MRI诊断：T2WI、DWI、MRS及其综合应用．磁共振成像, 2010, 1(4): 257-263.
[5]
曾洪武,王培军.磁共振扩散加权与弥散张量成像原理分析及比较.中国医学影像技术, 2005, 21(12):1945-1947.
[6]
王希明.前列腺癌分子水平成像：MRSI.国外医学临床放射学分册, 2005, 28(5):340-343.
[7]
Alonzi R, Padhani AR, Allen C. Dynamic contrast enhanced MRI in prostate cancer. Eur J Radiol, 2007, 63(3):335-350.
[8]
Quint LE, Van Erp JS, Bland PH, et al. Prostate cancer: correlation of MR images with tissue optical density at pathologic examination. Radiology, 1991, 179(4):837-842.
[9]
Ikonen S, Karkkainen P, Kivisaari L, et al. Endorectal magnetic resonance imaging of prostatic cancer: comparison between fat-suppressed T2-weighted fast spin echo and three-dimensional dualecho, steady-state sequences. Eur Radiol, 2001, 11(2):236-241.
[10]
Kim HJ, Choi CG, Lee DH, et al. High-b-value diffusion-weighted MR imaging of hyperacute ischemic stroke at 1.5T. AJNR, 2005, 26(2):208-215.
[11]
Gibbs P,Tozer DJ, Liney GP, et al.Comparison of quantitative T2 mapping and diffusion-weighted imaging in the normal and pathological protaste. Magn Reson Imaging, 2001, 46(6):1054-1058.
[12]
Issa B, et al. In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo-planar imaging. J Magn Reson Imaging, 2002, 16(2):196-200.
[13]
Hosseinzadeh K, Schwarz SD. Endorectal diffusion-weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue. J Magn Reson Imaging, 2004, 20(4):654-661.
[14]
Gibbs P, Pickles, Turnbull LW. Diffusion imaging of the prostate at 3.0 tesla. Invest Radiol, 2006, 41(2):185-188.
[15]
Shimofusa R, Fujimoto H, Akamata H, et al. Diffusion-weighted imaging of prostate cancer. J Comput Assist Tomogr, 2005, 29(2):149-153.
[16]
Kurhanewicz J, Vigneron DB, Males RG, et al. The prostate: MR imaging and spectroscopy. Radiol Clin North Am, 2000, 38(1):115-138.
[17]
Kurhanewicz J, Swanson MG, Wood PJ, et al. Magnetic resonance imaging and spectroscopic imaging: improved patient selection and potential for metabolic intermediate endpoints in prostate cancer chemoprevention trials. Urology, 2001, 57(Suppl 1):124-128.
[18]
Hahn P, Smith IC, Leboldus L, et al. The classification of benign and malignant human prostate tissue by multivariate analysis of 1H magnetic resonance spectra. Cancer Res, 1997, 57(16):3398-401.
[19]
Peter Swindle, Simon McCredie, et al. Pathologic Characterization of Human Prostate Tissue with Proton MR Spectroscopy. Radiology, 2003, 228(1):144-151.
[20]
Brown G, Macvicar DA, Ayton V, et al. The role of intravenous contrast enhancement in magnetic resonance imaging of prostatic carcinoma. Clin Radiol, 1995, 50(9):601-606.
[21]
Padhani AR, Gapinski CJ, Macvicar DA, et al. Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA. Clin Radiol, 2000, 55(2):99-109.
[22]
Engelbrecht MR, Huisman HJ, Laheij RJ, et al. Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. Radiology, 2003, 229(1):248-254.
[23]
Kim JK, Hong SS, Choi YJ, et al. Wash-in rate on the basis of dynamic contrast-enhanced MRI: usefulness for prostate cancer detection and localization. J Magn Reson Imaging, 2005, 22(5):639-646.
[24]
van Dorsten FA, van der Graaf M, Engelbrecht MR, et al. Combined quantitative dynamic contrast-enhanced MR imaging and (1)H MR spectroscopic imaging of human prostate cancer. J Magn Reson Imaging, 2004, 20(2):279-287.
[25]
Schlemmer HP, Merkle J, Grobholz R, et al. Can pre-operative contrast-enhanced dynamic MR imaging for prostate cancer predict microvessel density in prostatectomy specimens. Eur Radiol, 2004, 14(2):309-317.
[26]
Kozlowski P, Chang SD, Jones EC, et al. Combined diffusion-weighted and dynamic contrast-enhanced MRI for prostate cancer diagnosis--correlation with biopsy and histopathology. J Magn Reson Imaging, 2006, 24(1):108-113.
[27]
Ocak I, Bernardo M, Metzger G, et al. Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters. AJR Am J Roentgenol, 2007, 189(4):192-201.
[28]
Langer DL, van der Kwast TH, Evans AJ, et al. Prostate cancer detection with multi-parametric MRI: logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI. J Magn Reson Imaging, 2009, 30(2):327-334.
[29]
Engelbrecht MR, Jager GJ, Laheij RJ, et al. Local staging of prostate cancer using magnetic resonance imaging: a meta-analysis. Eur Radiol, 2002, 12(9):2294-2302.
[30]
Shukla-Dave A, Hricak H, Kattan MW, et al. The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis. BJU Int, 2007, 99(4):786-793.
[31]
Kirkham AP, Emberton M, Hoh IM, et al. MR imaging of prostate after treatment with high-intensity focused ultrasound. Radiology, 2008, 246(3):833-844.

PREV A perception on the development of the virtual scan technology for the magnetic resonance imaging
NEXT Sellar chondromyxoid fibroma: one case report
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn